Voltar
Revisão
BIBTEX RIS

Glutamic acid decarboxylase in insulin‐dependent diabetes mellitus

1992; Wiley; Volume: 8; Issue: 2 Linguagem: Catalão

10.1002/dmr.5610080205

ISSN

1099-0895

Autores

Henry J. DeAizpurua, Leonard C. Harrison,

Tópico(s)

Diabetes Management and Research

Resumo

Diabetes/Metabolism ReviewsVolume 8, Issue 2 p. 133-147 Article Glutamic acid decarboxylase in insulin-dependent diabetes mellitus Henry J. DeAizpurua, Henry J. DeAizpurua Burnet Clinical Research Unit, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville 3050, AustraliaSearch for more papers by this authorLeonard C. Harrison, Leonard C. Harrison Burnet Clinical Research Unit, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville 3050, AustraliaSearch for more papers by this author Henry J. DeAizpurua, Henry J. DeAizpurua Burnet Clinical Research Unit, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville 3050, AustraliaSearch for more papers by this authorLeonard C. Harrison, Leonard C. Harrison Burnet Clinical Research Unit, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville 3050, AustraliaSearch for more papers by this author First published: July 1992 https://doi.org/10.1002/dmr.5610080205Citations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Eisenbarth GS: Type 1 diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314: 1360–1368, 1986. 2 Foulis AK, Liddle CN, Farquharson MA, and Richmond JA: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29: 267–274, 1986. 3 Makino S, Kunimoto K, Muroaka Y, Mizushima Y, Katagiri K and Tochino Y: Breeding of a Non-Obese Diabetic Strain of Mice. Exp. Anim. 29 (1) 1–13, 1980. 4 Gleichman H, and Bottazzo GF: Islet cell and insulin autoantibodies in diabetes. Immunol Today 8: 157–168, 1987. 5 Harrison LC, Chu XS, DeAizpurua HJ, Graham M, Honeyman MC, and Colman PG: Islet-reactive T cells are a marker of pre-clinical insulin-dependent diabetes. J Clin Invest 89: 1161–1165, 1992. 6 Harrison LC, Colman P, Dean B, Baxter R, and Martin FIR: Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine. Diabetes 34: 1306–1308, 1985. 7 Campbell I, and Harrison L: Molecular pathology of type I diabetes. Mol Biol Med 7: 299–309, 1990. 8 Rayner ML, Harrison LC, Campbell IL, and Heyma P: Detection of insulin antibodies in newly-diagnosed type 1 diabetic children after “acid-stripping” of sera. Diabetes Res 6: 1–4, 1987. 9 Colman PG, Nayak RC, Campbell IL, and Eisenbarth GS: Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 37: 645–652, 1988. 10 Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludevigsson J, and Lernmark A: Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167–169, 1982. 11 Baekkeskov S, Aanstoot S, Christgau A, Reetz A, Solimena A, Cascalho M, Folli F, Richter-Olesen H, and DeCamilli P: Identification of the 64 k autoantigen in IDDM as the GABA-synthesizing enzyme GAD. Nature 347: 151–156, 1990. 12 Baekkeskov S, Dyrberg T, and Lernmark A: Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 224: 1348–1350, 1984. 13 Atkinson MA, and Maclaren NK: Autoantibodies in nonobese diabetic mice immunoprecipitate 64, 000-Mr islet antigen. Diabetes 37: 1587–1590, 1988. 14 Wang Y, Hao L, Gill RG, and Lafferty KJ: Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36: 535–538, 1987. 15 Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundquist G, and Lernmark A: Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926, 1987. 16 Christie M, Landin-Olssin M, Sundkvist G, Lernmark A, and Baekkeskov S: Antibodies to a Mr 64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 31: 597–602, 1988. 17 DeAizpurua HJ, Honeyman MC, and Harrison LC: Glutamic acid decarboxylase (GAD) in fetal pig proislets is recognised by antibodies and stimulates T cells from humans with pre-clinical insulin-dependent diabetes mellitus. J Autoimmun (submitted). 18 Christie M, Pipeleers D, Lernmark A, and Baekkeskov S: Cellular specificity of the 64 K islet antigen in type 1 diabetes. Diabetes 37: 5a, 1988. 19 Baekkeskov S, and Christie M: Characterization of the 64-kD membrane autoantigen in pancreatic β cells. In Current Communications in Molecular Biology, D Hanahan, HO McDevitt, and GF Cahill, Eds. Cold Spring Harbor Laboratory, 1989, pp 181–186. 20 Roep B, Kalian A, Hazenbos W, Bruining G, Bailyes E, Arden S, Hutton J, and de Vries R: T cell reactivity to a 38 kD insulin-reactivity-granule protein in patients with recent onset type 1 diabetes. Lancet 337: 439–1441, 1991. 21 Christie MR, Vohra G, Champagne P, Daneman D, and Delovitch TL: Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–794, 1990. 22 Christie M, Lernmark A, and Baekkeskov S: Subcellular localization of the 64 K islet cell antigen in type 1 diabetes. Diabetologia 30: 507A, 1987. 23 Christie MR, Pipeleers DG, Lernmark A, and Baekkeskov S: Cellular and subcellular localization of a Mr 64,000 protein autoantigen in IDDM. J Biol Chem 265: 376–381, 1990. 24 Baekkeskov S, Warnock G, Christie M, Rajotte RV, Larsen PM, and Fey S: Revelation of specificity of 64 K autoantibodies in IDDM sera by high-resolution 2-D gel electrophoresis. Diabetes 38: 1133–1141, 1989. 25 Colman P, Campbell IL, Kay TWH, and Harrison LC: The mol. wt 64,000 autoantigen in type I diabetes: evidence against its surface location on human islets. Diabetes 36: 1432–1440, 1987. 26 Baekkeskov S, Warnock G, Christie M, Rajotte RV, and Aagaard L: The 64,000 β-cell membrane autoantigen in type 1 (insulin-dependent) diabetes. Assembly of two and three polypeptide chains by disulphide bridging. Diabetologia 31: 466A, 1988. 27 Kämpe O, Andersson A, Björk E, Hallberg A, and Karlsson FA: High-glucose stimulation of 64, 000-Mr islet cell autoantigen expression. Diabetes 38: 1326–1328, 1989. 28 Collins HW, Buettger C, and Matschinsky F: High-resolution two-dimensional Polyacrylamide gel electrophoresis reveals a glucose-response protein of 65 kDa in pancreatic islet cells. Proc Natl Acad Sci USA 87: 5494–5489, 1990. 29 Gerling I, and Chatterjee NK: Autoantigen (64, 000-Mr) expression in Coxsackievirus B4-induced experimental diabetes. Curr Topics Microbiol Immunol 156: 55–62. 30 Hedeskov CJ: Mechanism of glucose-induced insulin secretion. Physiol Rev 60: 442–507, 1980. 31 Harrison LC, Campbell IL, Colman PG, Chosich N, Kay TWH, Tait B, Bartholomeusz RK, DeAizpurua H, Joseph JL, Chu S, and Kielczynski WE: Type 1 diabetes: immunology and immunotherapy. Adv Endocrinol Metab 1: 35–94, 1990. 32 Solimena M, Folli F, Denis-Donini S, Comi GC, DeCamilli P, and Vicari AM: Autoantibodies to glutamic acid decarboxylase in a patient with stiff man syndrome, epilepsy and type 1 diabetes mellitus. N Engl J Med 318: 1012–1020, 1988. 33 Solimena M, Folli F, Aparisi R, and Pozza G: Autoantibodies to GABA-ergic neurones and pancreatic beta cells in stiff man syndrome. N Engl J Med 322: 1555–1560, 1990. 34 Vincent SR, Hökfelt T, Wu JY, Elde RP, Morgan LM, and Kimmel JR: Immunohistochemical studies of the BAGA system in the pancreas. Neuroendocrinology 36: 197–204, 1983. 35 Christie MR, Brown TJ, and Cassidy D: Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35: 380–384, 1992. 36 Molinoff PB, and Krawitz EA: The metabolism of γ-aminobutyric and GABA in the lobster nervous system—glutamic decarboxylase. J Neurochem 15: 391–409, 1968. 37 Jackson FR: Prokaryotic and eukaryotic pyridoxal dependent decarboxylases are homologous. J Mol Evol 31: 325–329, 1990. 38 Spink DC, Wu SJ, and Martin DL: Multiple forms of glutamate decarboxylase in porcine brain. J Neurochem 40: 1113–1119, 1983. 39 Spink DC, Porter TG, Wu SJ, and Martin DL: Characterization of three kinetically distinct forms of glutamate decarboxylase from pig brain. Biochem J 231: 695–703, 1985. 40 Blindermann J-M, Maitre M, Ossola L, and Mandel P: Purification and some properties of L-glutamate decarboxylase from human brain. Eur J Biochem 86: 143–152, 1978. 41 Spink DC, Porter TG, Wu SJ, and Martin DL: Kinetically different, multiple forms of glutamate decarboxylase in rat brain. Brain Res 421: 235–244, 1987. 42 Roberts E, and Frankel S: γ-Aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 187: 55–63, 1950. 43 Chang Y-C, and Gottlieb DI: Characterization of the protein purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci 8: 2123–2130, 1988. 44 Zachman M, Tocci P, and Nyhan WL: The occurrence of γ-aminobutyric acid in human tissues other than brain. J Biol Chem 241: 1355–1358, 1966. 45 Whelan DT, Scriver CR, and Mohyuddin F: Glutamic acid decarboxylase and gamma-amino-butyric acid in mammalian kidney. Nature (London) 234: 916–917, 1969. 46 Okada Y, Toniguchi H, and Shimada C: High concentrations of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science 194: 620–622, 1976. 48 Expression of glutamic acid decarboxylase. J Neurochem 54: 1068–1078, 1990. 49 Fahn S: Regional distribution studies of GABA and other putative transmitters and their enzymes. In: GABA in Nervous System Function. E Roberts, TN Chase, and DB Tower, Eds. Raven Press, New York, 1976, 169–187. 50 Gonzalez NN, Alfie J, and Fiszer de Plazas S: Glutamic acid decarboxylase in different areas of the developing chick central nervous system. Neurochem Res 15: 917–921, 1990. 51 Litwak J, Merugliano M, Chesselet MF, and Olhrtans GA: Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firing. Neurosci Lett 116: 179–183, 1990. 52 Caboche J, Vernier P, Julien JF, Rogard M, Mallet J, and Benson MJ: Parallel decrease of glutamic acid decarboxylase and pre-pro-eukaphalia mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist. J Neurochem 56: 428–435, 1991. 53 Benson DL, Isackson PJ, Gull CM, and Jones EG: Differential effects of mononuclear deprivation on glutamic acid decarboxylase and type II calcium-calmodulin-dependent protein kinase gene expression in the adult monkey visual cortex. J Neurosci 11: 31–47, 1991. 54 Bond RW, Jansen KR, and Gottlieb DI: Pattern of expression of glutamic acid decarboxylase mRNA in the developing rat brain. Proc Natl Acad Sci USA 85: 3231–3234, 1988. 55 Bond RW, Wygorski RJ, and Gottlieb DI: Develop-mentally regulated expression of an exon containing a stop codon in the gene for glutamic acid decarboxylase. Proc Natl Acad Sci USA 87: 8771–8775, 1990. 56 Huang WM, Fourquest LR, Wu E, and Wu JY: Molecular cloning and amino acid sequence of brain L-glutamate decarboxylase. Proc Natl Acad Sci USA 87: 8491–8495, 1990. 57 Wyborski RJ, Bond RW, and Gottlieb DI: Characterization of a cDNA coding for rat glutamic acid decarboxylase. Mol Brain Res 8: 193–198, 1990. 58 Julien JF, Sommana P, and Mallet J: Rat brain glutamic acid decarboxylase sequence from a cloned cDNA. J Neurochem 54: 703–705, 1990. 59 Cram DS, Barnett LD, Joseph JL, and Harrison LC: Cloning and partial nucleotide sequence of human glutamic acid decarboxylase (GAD) cDNA from brain and pancreatic islets. Biochem Biophys Res Commun 176: 1239–1244, 1991. 60 Brilliant MH, Szabo G, Karanova Z, Kozak CA, Gloser TM, Greenspan RJ, and Housman DE: Sequence homologies to glutamic acid decarboxylase cDNA are present on mouse chromosomes 2 and 10. Genomics 6: 115–122, 1990. 61 Kaufman DL, McGinnis JF, Krieger NR, and Tobin AJ: Brain glutamate decarboxylase cloned in λ-gt11 fusion protein produces γ-aminobutyric acid. Science 232: 1138–1140, 1986. 62 Kaufman DL, Houser CR, and Tobin AJ: Two forms of the GABA synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 56: 720–723, 1991. 63 Legay F, Pelhate S, and Tappaz ML: Phylogenesis of brain glutamic acid decarboxylase from vertebrates: immunochemical studies. J Neurochem 46: 1478–1486, 1986. 64 Erlander MG, and Tobin AJ: The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res 16: 216–226, 1991. 65 Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, and Tobin AJ: Two genes encode distinct glutamate decarboxylases. Neuron 7: 91–100, 1991. 66 Michelsen BK, Petersen JS, Boel S, Møldrup A, Dyrberg T, and Madsen OD: Cloning, characterization and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 88: 8854–8758, 1991. 67 Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Bärmeier H, Mathewes S, Grant FJ, Foster D, and Lernmark A: Cloning and primary structure of human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 88: 8337–8341, 1991. 68 Bu D-F, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wagner-McPherson CB, Evans GA, and Tobin AJ: Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sa USA 89. 2115–2119, 1992. 69 Solimena M, and DeCamilli P: Autoimmunity to glutamic acid decarboxylase (GAD) in stiff man syndrome and insulin-dependent diabetes mellitus. TINS 14: 452–457, 1991. 70 Martino GV, Tappaz ML, Braghi S, Dozio N, Cannai N, Pozza G, Bottazzo GF, Grimaldi LME, and Bosi E: Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immunotrapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies. J Autoimmun 4: 915–923, 1991. 71 Rowley MJ, Mackay IR, Chen Q-Y, Knowles WJ, and Zimmet PZ: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548–551, 1992. 72 DeAizpurua HJ, Wilson Y, and Harrison LC: Glutamic acid decarboxylase (GAD) autoantibodies in islet cell antibody (ICA) positive relatives of insulin-dependent diabetics. Proc Natl Acad Sci USA (in press). 73 DeAizpurua HJ, Harrison LC, and Cram DS: An ELISA for antibodies to recombinant glutamic acid decarboxylase in insulin-dependent diabetes. Diabetes (in press). a Schmidli R, DeAizpurua HJ, Colman PG and Harrison LC, Diabetes (submitted). 74 Christgau S, Schierbeck H, Aanstoot HJ, Begley K, Kofod H, Heunoes K, and Baekkeskov S: Pancreatic β cells express two autoantigenic forms of glutamic acid decarboxylase, a 65 kDa hydrophilic form and a 64 kDa amphiphilic form which can be both membrane bound and soluble. J Biol Chem 266: 21257–21264, 1991. 75 Wicker LS, Miller B-J, and Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 20: 855–860, 1986. 76 Koevary S, Rossini A, Stoller W, Chick W, and Williams RM: Passive transfer of diabetes in the BB/W rat. Science 220: 727–728, 1983. 77 Nerup J, Andersen OO, Bendixen G, Egeberg J, and Poulsen JE: Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes 20: 424–427, 1971. 78 Huang S-W, and Maclaren NK, Insulin-dependent diabetes: a disease of autoaggression. Science 192: 64–66, 1976. 79 Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, and Golden M: Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell autotoxicity in humans. J Immunol 130: 1189–1194, 1983. 80 Lampeter E, Bierwolf B, Krug J, Verlohren H-J, Lohmann D, and Cossel L: Electron microscopical investigations on lymphocyte cytotoxicity against beta cells in recent-onset IDDM. Diabetes Res 6: 159–167, 1987. 81 Boitard C, Debray-Sachs M, Pouplard S, Assan R, and Hamburger J: Lymphocytes from diabetes suppress insulin release in vitro. Diabetologia 21: 41–46, 1981. 82 DeBerardinis P, Londei M, James RFL, Lake SP, Wise PH, and Feldmann M: Do CD4-positive cytotoxic T cells damage islet β cells in type 1 diabetes? Lancet 2: 823–824, 1988. 83 Van Vliet E, Roep BO, Meulenbroek L, Bruining GJ, and DeVries RRP: Human T cell clones with specificity for insulinoma cell antigens. Eur J Immunol 19: 213–216, 1989. 84 Harrison LC, DeAizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, and Colman PG: Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with pre-clinical and clinical insulin-dependent diabetes. Diabetes 40: 1128–1133, 1991. 85 Harrison LC, Honeyman MC, DeAizpurua HJ, Colman PG, and Cram DS: Autoreactive T cells and islet autoantigens in human IDDM. Diabetes Res Clin Vrac 14 (Suppl 1): S19, 1991. 86 Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, and Maclaren NK: Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458–459, 1992. 87 Diaz J-L, Ways J, and Hammonds P: T-lymphocyte lines specific for glutamic acid decarboxylase (GAD), the 65K β-cell antigen of IDDM. Diabetes 41: 118–121, 1992. 88 Genovese S, Cassidy D, Bonifacio E, Bottazzo GF, and Christie MR: Antibodies to 37/40 kD tryptic fragments of 64 kD antigen are markers of rapid progression to type 1 insulin-dependent diabetes. Diabetes Res Clin Prac 14 (Suppl 1): S11, 1991. 89 Genovese S, Bonifacio E, Christie MR, McNally JM, Dean BM, Wagner R, Bosi E, and Bottazzo GF: Whole islet staining islet cell antibodies and antibodies to 37/40 kD tryptic fragments of 64 kD antigen are the most predictive markers for IDDM. Diabetes Res Clin Prac 14 (Suppl 1): S11, 1991. 90 Bonifacio E, Bingley PJ, Shattock M, Dean B, Dunger D, Gale EA, and Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147–149, 1990. 91 Palmer JP, Asplin CM, Clemon P, Lyer K, Tatpati O, Raghu PK, and Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339, 1982. 92 Srikanta S, Ricter AT, McCulloch DK, Soeldner JS, Eisenbarth GS, and Palmer JP: Autoimmunity to insulin, beta cell dysfunction and development of insulin-dependent diabetes mellitus. Diabetes 35: 139–142, 1986. 93 Ludvigssn J, Binder C, and Mandrup-Poulson J: Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children. Diabetologia 31: 647–651, 1988. 94 Thivolet Ch, Beaufrére B, Bétuel H, Gebuhrer L, Chatelain P, Durand A, Tourniaire J, and Francois R: Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study. Diabetologia 31: 741–746, 1988. 95 Armitage M, Wilkin T, Scott-Morgan L, Casey C, and Betts P: On the relationship between islet cell antibodies and insulin autoantibodies in patients at risk from insulin-dependent diabetes. Autoimmunity 1: 275–283, 1988. 96 Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, and Eisenbarth GS: Life-table analyses of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38: 1320–1325, 1989. 97 Landen-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, and Sundkuist G: Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387–395, 1989. 98 Maclaren N, Riley W, Silverstein J, Schatz D, and Atkinson M: Progress towards the prevention of insulin-dependent diabetes: the Gainesville studies. In Immunotherapy of Type 11 Diabetes. D Andreani, H Kolb, and P Pozzilli, Eds. Wiley, New York, 1989, 147–154. 99 Gianani R, Jackson R, and Eisenbarth GS: Evidence that the autoantigen of restricted ICA is GAD. Diabetes Res Clin Prac 14 (Suppl 1): S13, 1991. 100 Atkinson M, Kaufman D, Erlander M, Tobin A, Brown L, and Maclaren N: Islet cell cytoplasmic autoantibodies (ICA) in insulin-dependent diabetes are not reactive to glutamate decarboxylase (GAD) 65 or 67. Diabetes Res Clin Prac 14 (Suppl 1): S13, 1991. 101 Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, and Riley WJ: 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357–1360, 1990. 102 Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EAM, and Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia (in press). 103 Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, and Tobin AJ: Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89: 283–292, 1992. 104 Street NG, and Mosman TR: Functional diversity of T-lymphocytes due to secretion of different cytokine patterns. FASEB J 5: 171–177, 1991. 105 Czaznocka B, Ruf J, Ferrand M, Carayon P, and Lissitzky S: Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid disease. FEBS Lett 190: 147–152, 1985. 106 Karlsson FA, Burman P, Lóóf L, and Mardh S: Major parietal cell antigen in autoimmune gastritis with pernicious anaemia is the acid producing H+,K+ adenosine triphosphatase of the stomach. J Clin Invest 81: 475–479, 1988. 107 Coppel RL, McNeilage LJ, Surh CD, Van de Water J, Spithill TW, Whittingham S, and Gershwin ME: Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 85: 7317–7321, 1988. 108 Krohn K, Uibo R, Aavik E, Peterson P, and Savilahti K: Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylase. Lancet 339: 770–773, 1992. 109 Zangler UM, Hauri HP, Loepez J, Homburg J-C, and Meyer UA: Antibodies against human cytochrome P-450 db-1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 85: 8256–8260, 1988. Citing Literature Volume8, Issue2July 1992Pages 133-147 ReferencesRelatedInformation

Referência(s)